SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

SIE

209.45

+2.95%↑

AIR.FR

165.7

+2.82%↑

ENR.DE

147.6

+3.91%↑

RHM

1,475.5

-1.83%↓

HO

239.6

-0.13%↓

Search

Bollore SA.

Closed

SectorIndustrials

4.798 -0.83

Overview

Share price change

24h

Current

Min

4.736

Max

4.836

Key metrics

By Trading Economics

Income

240M

Sales

1.5B

P/E

Sector Avg

39.982

61.065

Dividend yield

1.81

Profit margin

15.514

Employees

3,086

EBITDA

533M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+7.44% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.81%

2.23%

Market Stats

By TradingEconomics

Market Cap

12B

Previous open

5.63

Previous close

4.798

News Sentiment

By Acuity

55%

45%

332 / 406 Ranking in Industrials

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Bollore SA. Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Bollore SA. Forecast

Price Target

By TipRanks

7.44% upside

12 Months Forecast

Average 5.2 EUR  7.44%

High 5.2 EUR

Low 5.2 EUR

Based on 1 Wall Street analysts offering 12 month price targets forBollore SA. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

5.395 / 5.505Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

332 / 406 Ranking in Industrials

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bollore SA.

Bolloré SE engages in the transportation and logistics, communications, and industry businesses in France, rest of Europe, the Americas, Asia, Oceania, and Africa. It operates through Bolloré Logistics, Bolloré Energy, Communications, and Industry segments. The company offers freight forwarding, railroad, and port services; and distributes oil products. It also provides advertising, and communication consulting services; owns and publishes Cnews, a French daily newspaper; provides ticketing and venue services; acts as a pay-TV operator; and operates Mac-Mahon cinema theaters. In addition, it develops batteries based on lithium metal polymer technology for use in electric buses and energy storage solutions, as well as in stationary applications; and polypropylene films for capacitors and electrical components. Further, the company integrates identification, tracking, and mobility solutions for retail, transport, and logistics; provides equipment for pedestrian and vehicle access control; and electric shuttles solutions. The company was founded in 1822 and is based in Puteaux, France. Bolloré SE is a subsidiary of Financière de l'Odet SE.
help-icon Live chat